Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine-Reference-Cited by-同舟云学术

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine

Published:2005-08-12 Issue:12 Volume:19 Page:1321-1323
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Dorrell Lucy,Yang Hongbing,Iversen Astrid KN,Conlon Christopher,Suttill Annie,Lancaster Mary,Dong Tao,Cebere Inese,Edwards Anne,Rowland-Jones Sarah,Hanke Tomáš,McMichael Andrew J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference13 articles.

1. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya;Hanke;Nat Med,2000

2. Safety and immunogenicity of ALVAC vCP1452and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy;Jin;J Virol,2002

3. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multi-epitope DNA prime-modified vaccinia virus Ankara boost vaccination regimen;Hanke;J Virol,1999

4. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans;McConkey;Nat Med,2003

5. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination;Barouch;Science,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Overview of Advances in Universal Influenza Vaccines Based on T-Cell Immunity;Advances in Clinical Medicine;2023

2. Progress Towards a Therapeutic HIV DNA Vaccine;Expert Review of Vaccines;2022-04-06

3. In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?;Viruses;2021-03-18

4. Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B;Vaccines;2019-11-07

5. New challenges in therapeutic vaccines against HIV infection;Expert Review of Vaccines;2017-05-04